Mode
Text Size
Log in / Sign up

Failed Back Surgery Syndrome

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Failed Back Surgery Syndrome

9 trials tracked for Failed Back Surgery Syndrome: 4 in phase 3 or 4 and 2 with published results. The most-cited published study has 149 citations.

9Trials tracked
4Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 3 Phase 3 1 Other / NA 5
  1. Phase 4 Spinal Cord Stimulation for Predominant Low Back Pain Completed · 149 cited
  2. Phase 4 Determining the Prognostic Value of Continuous Intrathecal Infusion Completed · 11 cited
  3. Phase 4 Efficacy of Pregabalin in Patients With Radicular Pain Completed
  4. Phase 3 An Implantable Spinal Cord Stimulation Pain Management System Completed
  5. N/A Spinal Cord Stimulation Frequency Study Completed
  6. N/A Spinal Cord Stimulation in Patients With Post-Laminectomy Syndrome in Testing Phase Completed
Show 3 more trials
  1. N/A Intraoperative Neuromonitoring Recording With a Novel SCS Paddle Completed
  2. N/A A Study to Confirm the Safety of High Frequency DRG Stimulator in Patients With Chronic Lower Limb Pain Completed
  3. N/A Sensory Testing of Multiple Forms of Spinal Cord Stimulation for Pain Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found Updated — new results For clinicians

Failed Back Surgery Syndrome: what the trials found

Optimal Medical Management (OMM) has been shown to significantly improve outcomes for patients with failed back surgery syndrome compared to alternative treatments. Specifically, OMM resulted in a significantly higher proportion of subjects achieving at least a 50% reduction in low back pain intensity (p=0.036). Patients receiving OMM also demonstrated statistically significant improvements in both low back pain intensity (p<0.001) and leg pain intensity (p<0.001) as measured by the Numeric Pain Rating Scale (NPRS) 2.

Precision Spinal Cord Stimulation (SCS) has demonstrated a reduction in Visual Analog Scale (VAS) scores from baseline to 2 weeks post-initial fitting 5. Other interventions, such as Bupivacaine, have been evaluated for pain and disability; however, specific comparative efficacy data against other standard treatments were not provided in the reported outcomes 3. Pregabalin was also studied, but results did not show statistically significant differences in pain scores (p=0.279), global impression of change (p=0.282), or Oswestry Disability Questionnaires (p=0.139) at 3 weeks 4.

Recent results — preliminary, needs further review

  • Spinal Cord Stimulation (SCS) was evaluated for its impact on Temporal Summation (TS); however, the results did not reach statistical significance (p=0.2375) 1.
  • Conventional spinal cord stimulation showed a range of percentage changes in VAS scales at the end of treatment, but these findings were not statistically significant (p=0.589) 7.

For the clinician treating this condition

  • Optimal Medical Management (OMM) is an effective intervention for reducing both low back pain and leg pain intensity in patients with failed back surgery syndrome 2.
  • Precision Spinal Cord Stimulation (SCS) can lead to measurable reductions in Visual Analog Scale (VAS) scores within 2 weeks of fitting 5.

AI synthesis of 6 cited trials, updated Jun 21, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.